Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
129Xe MRI for Diagnosis of Pulmonary Vascular Disease
NCT03078192Phase 2Completed
- Start
- May 2017
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hyperpolarized xenon gas in pulmonary vascular disease (PVD). Started May 2017; status: completed.
02
Drugs
hyperpolarized xenon gas
03
Conditions
pulmonary vascular disease (PVD)
Beyond the preview
Go deeper on NCT03078192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03078192.